메뉴 건너뛰기




Volumn 70, Issue 2, 2002, Pages 149-153

Multiple sclerosis associated with interferon-alpha therapy for chronic myelogenous leukemia

Author keywords

Allogeneic bone marrow transplantation; Autoimmune disease; Cellular immunity; Chronic myelogenous leukemia; Interferon alpha; Multiple sclerosis

Indexed keywords

ALPHA INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

EID: 0036105496     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10090     Document Type: Article
Times cited : (18)

References (26)
  • 9
    • 0021035886 scopus 로고
    • Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
    • (1983) Neurology , vol.33 , pp. 1444-1452
    • Kurtzke, J.F.1
  • 17
    • 0029111697 scopus 로고
    • Treatment of marrow stroma with interferon-alpha restores normal beta I integrin-dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors. Role of MIP-alpha
    • (1995) J Clin Invest , vol.96 , pp. 931-939
    • Bhatia, R.1    McGlave, P.B.2    Verfaillie, C.M.3
  • 22
    • 0035134688 scopus 로고    scopus 로고
    • Interferon in oncological practice: Review of interferon biology, clinical applications, and toxicities
    • (2001) Oncologist , vol.6 , pp. 34-55
    • Jonasch, E.1    Haluska, F.G.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.